Literature DB >> 19481939

Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study.

Karim Wahbi1, Christophe Meune, Henri Marc Bécane, Pascal Laforêt, Guillaume Bassez, Arnaud Lazarus, Hélène Radvanyi-Hoffman, Bruno Eymard, Denis Duboc.   

Abstract

In contrast with Steinert's disease (DM1), type 2 muscular dystrophy (DM2) is not known to be associated with a high prevalence of cardiac involvement. Our objective was to compare the results of detailed cardiac investigations in populations of DM2 and DM1 patients, and in controls. Thirty-eight DM2 patients (17 males; age=57.1+/-15.2years) were investigated for possible heart involvement, and their results compared with 76 age-sex matched DM1 patients and 76 controls. Cardiac abnormalities were present in 15 DM2 patients, including conductive defects in 14, systolic dysfunction in 6, supraventricular arrhythmias in 6 and stroke in 5 patients and were significantly more frequent than in controls. When compared to DM1 patients, conductive defects were less frequent, supraventricular arrhythmias had similar prevalence and there was a trend towards more frequent left ventricular dysfunction in DM2 patients. Our study suggests that systematic cardiac investigations should be recommended in these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19481939     DOI: 10.1016/j.nmd.2009.04.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

Review 1.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 2.  Myotonic dystrophy.

Authors:  Charles A Thornton
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

Review 3.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

4.  Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.

Authors:  Teresa M Lee; Mathew S Maurer; Izabela Karbassi; Corey Braastad; Sat D Batish; Wendy K Chung
Journal:  Congest Heart Fail       Date:  2011-11-03

5.  Stroke and Stroke-like Episodes in Muscle Disease.

Authors:  Josef Finsterer
Journal:  Open Neurol J       Date:  2012-05-18

6.  A Molecular Signature of Myalgia in Myotonic Dystrophy 2.

Authors:  Rabih Moshourab; Vinko Palada; Stefanie Grunwald; Ulrike Grieben; Gary R Lewin; Simone Spuler
Journal:  EBioMedicine       Date:  2016-03-14       Impact factor: 8.143

7.  Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  J Neuromuscul Dis       Date:  2015-07-22

8.  Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies.

Authors:  Johannes Schmid; Meinrad Beer; Andrea Berghold; Tatjana Stojakovic; Hubert Scharnagl; Benjamin Dieplinger; Stefan Quasthoff; Josepha S Binder; Peter P Rainer
Journal:  ESC Heart Fail       Date:  2020-05-31

Review 9.  Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila.

Authors:  Mouli Chakraborty; Beatriz Llamusi; Ruben Artero
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

10.  TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2.

Authors:  Francesca Bosè; Laura Valentina Renna; Barbara Fossati; Giovanni Arpa; Valentina Labate; Valentina Milani; Annalisa Botta; Emanuele Micaglio; Giovanni Meola; Rosanna Cardani
Journal:  Front Neurol       Date:  2019-09-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.